Cumberland Fixed Asset Turnover from 2010 to 2024

CPIX Stock  USD 1.40  0.03  2.19%   
Cumberland Pharmaceuticals Fixed Asset Turnover yearly trend continues to be fairly stable with very little volatility. Fixed Asset Turnover will likely drop to 5.34 in 2024. During the period from 2010 to 2024, Cumberland Pharmaceuticals Fixed Asset Turnover regression line of annual values had r-squared of  0.32 and arithmetic mean of  35.96. View All Fundamentals
 
Fixed Asset Turnover  
First Reported
2010-12-31
Previous Quarter
5.61642132
Current Value
5.34
Quarterly Volatility
24.70980853
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.1 M, Interest Expense of 701.3 K or Selling General Administrative of 8.9 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0 or PTB Ratio of 0.82. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Latest Cumberland Pharmaceuticals' Fixed Asset Turnover Growth Pattern

Below is the plot of the Fixed Asset Turnover of Cumberland Pharmaceuticals over the last few years. It is Cumberland Pharmaceuticals' Fixed Asset Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cumberland Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Fixed Asset Turnover10 Years Trend
Slightly volatile
   Fixed Asset Turnover   
       Timeline  

Cumberland Fixed Asset Turnover Regression Statistics

Arithmetic Mean35.96
Geometric Mean25.82
Coefficient Of Variation68.71
Mean Deviation20.85
Median36.37
Standard Deviation24.71
Sample Variance610.57
Range72.4659
R-Value(0.56)
Mean Square Error449.91
R-Squared0.32
Significance0.03
Slope(3.10)
Total Sum of Squares8,548

Cumberland Fixed Asset Turnover History

2024 5.34
2023 5.62
2022 7.63
2021 24.53
2020 14.39
2019 9.27
2018 52.83

About Cumberland Pharmaceuticals Financial Statements

Cumberland Pharmaceuticals investors use historical fundamental indicators, such as Cumberland Pharmaceuticals' Fixed Asset Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Fixed Asset Turnover 5.62  5.34 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.